Scientific Literature Search

Source record

Animal models of Parkinson's disease: a gateway to therapeutics?

Le W, Sayana P, Jankovic J.

Neurotherapeutics · 2014-01-01

DOI: 10.1007/s13311-013-0234-1PMID: 24158912

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Dual ligands targeting dopamine D2 and serotonin 5-HT1A receptors as new antipsychotical or anti-Parkinsonian agents.

Ye N, Song Z, Zhang A.

Curr Med Chem · 2014-01-01

DOI: 10.2174/09298673113206660300PMID: 24164194

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Novel approach to the role of NMDA receptors in traumatic brain injury.

Shohami E, Biegon A.

CNS Neurol Disord Drug Targets · 2014-01-01

DOI: 10.2174/18715273113126660196PMID: 24168367

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

α-Synuclein ubiquitination and novel therapeutic targets for Parkinson's disease.

Rott R, Szargel R, Shani V, Bisharat S, Engelender S.

CNS Neurol Disord Drug Targets · 2014-01-01

DOI: 10.2174/18715273113126660195PMID: 24168368

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

MRI reveals brain abnormalities in drug-naive Parkinson's disease.

Planetta PJ, McFarland NR, Okun MS, Vaillancourt DE.

Exerc Sport Sci Rev · 2014-01-01

DOI: 10.1249/jes.0000000000000003PMID: 24188978

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Cortical effects of deep brain stimulation: implications for pathogenesis and treatment of Parkinson disease.

Li Q, Qian ZM, Arbuthnott GW, Ke Y, Yung WH.

JAMA Neurol · 2014-01-01

DOI: 10.1001/jamaneurol.2013.4221PMID: 24189904

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Cognitive and motor function in long-duration PARKIN-associated Parkinson disease.

Alcalay RN, Caccappolo E, Mejia-Santana H, Tang MX, Rosado L, Orbe Reilly M, Ruiz D, Louis ED, Comella CL, Nance MA, Bressman SB, Scott WK, Tanner CM, Mickel SF, Waters CH, Fahn S, Cote LJ, Frucht SJ, Ford B, Rezak M, Novak KE, Friedman JH, Pfeiffer RF, Marsh L, Hiner B, Payami H, Molho E, Factor SA, Nutt JG, Serrano C, Arroyo M, Ottman R, Pauciulo MW, Nichols WC, Clark LN, Marder KS.

JAMA Neurol · 2014-01-01

DOI: 10.1001/jamaneurol.2013.4498PMID: 24190026

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

Quality of life in organ transplant recipients participating in an online transplant community.

Wicks P, Sulham KA, Gnanasakthy A.

Patient · 2014-01-01

DOI: 10.1007/s40271-013-0033-0PMID: 24194474

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Surgical treatment of Parkinson's disease: patients, targets, devices, and approaches.

Wagle Shukla A, Okun MS.

Neurotherapeutics · 2014-01-01

DOI: 10.1007/s13311-013-0235-0PMID: 24198187

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Long-term clinical outcome of fetal cell transplantation for Parkinson disease: two case reports.

Kefalopoulou Z, Politis M, Piccini P, Mencacci N, Bhatia K, Jahanshahi M, Widner H, Rehncrona S, Brundin P, Björklund A, Lindvall O, Limousin P, Quinn N, Foltynie T.

JAMA Neurol · 2014-01-01

DOI: 10.1001/jamaneurol.2013.4749PMID: 24217017

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

An 85-year old male with levodopa-responsive parkinsonism followed by dementia and supranuclear ophthalmoplegia caused by alzheimer-type pathology without Lewy bodies.

Kasahata N, Hagiwara M, Kato H, Nakamura A, Uchihara T.

J Alzheimers Dis · 2014-01-01

DOI: 10.3233/jad-131508PMID: 24217279

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Mitochondrial enhancement for neurodegenerative movement disorders: a systematic review of trials involving creatine, coenzyme Q10, idebenone and mitoquinone.

Liu J, Wang LN.

CNS Drugs · 2014-01-01

DOI: 10.1007/s40263-013-0124-4PMID: 24242074

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

187.286 articles found

Animal models of Parkinson's disease: a gateway to therapeutics?

Dual ligands targeting dopamine D2 and serotonin 5-HT1A receptors as new antipsychotical or anti-Parkinsonian agents.

Novel approach to the role of NMDA receptors in traumatic brain injury.

α-Synuclein ubiquitination and novel therapeutic targets for Parkinson's disease.

MRI reveals brain abnormalities in drug-naive Parkinson's disease.

Cortical effects of deep brain stimulation: implications for pathogenesis and treatment of Parkinson disease.

Cognitive and motor function in long-duration PARKIN-associated Parkinson disease.

Quality of life in organ transplant recipients participating in an online transplant community.

Surgical treatment of Parkinson's disease: patients, targets, devices, and approaches.

Long-term clinical outcome of fetal cell transplantation for Parkinson disease: two case reports.

An 85-year old male with levodopa-responsive parkinsonism followed by dementia and supranuclear ophthalmoplegia caused by alzheimer-type pathology without Lewy bodies.

Mitochondrial enhancement for neurodegenerative movement disorders: a systematic review of trials involving creatine, coenzyme Q10, idebenone and mitoquinone.

Filters